LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis

JACC: Cardiovascular Imaging

Volumn 9, Issue 6, 2016, Pages 680-686

  Boynton, Samuel J ^a   Geske, Jeffrey B ^a   Dispenzieri, Angela ^a   Syed, Imran S ^a   Hanson, Theodore J ^a   Grogan, Martha ^a   Araoz, Philip A ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

amyloidosis; enhancement; magnetic resonance imaging; outcomes; prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; GADODIAMIDE; TROPONIN T; CONTRAST MEDIUM; GADOLINIUM PENTETATE; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AMYLOID LIGHT CHAIN CARDIAC AMYLOIDOSIS; ARTICLE; BODY MASS; CARDIAC MAGNETIC RESONANCE LATE GADOLINIUM ENHANCEMENT; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; ECHOCARDIOGRAPHY; ENDOCARDIUM; FEMALE; FOLLOW UP; HEALTH CARE; HEART; HEART AMYLOIDOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; STAGING; AGED; AMYLOIDOSIS; BLOOD; CARDIOMYOPATHY; CHI SQUARE DISTRIBUTION; CINE MAGNETIC RESONANCE IMAGING; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; IMMUNOLOGY; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AGED; AMYLOIDOSIS; BIOMARKERS; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84975480493     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2015.10.027     Document Type: Article

References (12)

1. 1 Kyle, R.A., Linos, A., Beard, C.M., et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 79 (1992), 1817–1822.
2. 2 Falk, R.H., Comenzo, R.L., Skinner, M., The systemic amyloidoses. N Engl J Med 337 (1997), 898–909.
3. 3 Kyle, R.A., Gertz, M.A., Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32 (1995), 45–59.
4. 4 Syed, I.S., Glockner, J.F., Feng, D., et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img 3 (2010), 155–164.
5. 5 Austin, B.A., Tang, H., Rodriguez, E.R., et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. J Am Coll Cardiol Img 2 (2009), 1369–1377.
6. 6 Migrino, R.Q., Christenson, R., Szabo, A., Bright, M., Truran, S., Hari, O., Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys, 9, 2009, 5.
7. 7 White, J.A., Kim, H.W., Shah, D., et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. J Am Coll Cardiol Img 7 (2014), 143–156.
8. 8 Fontana, M., Pica, S., Reant, P., et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132 (2015), 1570–1579.
9. 9 Dispenzieri, A., Gertz, M.A., Kyle, R.A., et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 22 (2004), 3751–3757.
10. 10 Maceira, A.M., Prasad, S.K., Hawkins, P.N., Roughton, M., Pennell, D.J., Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson, 10, 2008, 54.
11. 11 Ruberg, F.L., Appelbaum, E., Davidoff, R., et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103 (2009), 544–549.
12. 12 Banypersad, S.M., Fontana, M., Maestrini, V., et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36 (2015), 244–251.